Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03544242 · ClinicalTrials.gov registry record · Phase 2
Nitrite Infusion in Islet Cell Transplantation
A Phase 2 study, sponsored by University of Alabama at Birmingham.
- Terminated
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT03544242: Clinical Trial Phase 2 study, sponsored by University of Alabama at Birmingham.
NCT03544242 is a Phase 2 study that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 4 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03544242, a Phase 2 study, was terminated before completion, sponsored by University of Alabama at Birmingham.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study seeks to investigate the effects of administering nitrite to pancreatic islet cells that have been removed from a patient for autotransplantation.
Primary Outcome
Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.
Interventions
- OTHER Control
- DRUG Pre-Isolation Infusion
- DRUG Post-Isolation Infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2017-05-07 |
| Est. Completion | 2019-06-27 |
| Phase | Phase 2 |
Why NCT03544242 stopped before completion
NCT03544242 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT03544242 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03544242 about?
NCT03544242 is a clinical study titled "Nitrite Infusion in Islet Cell Transplantation". This study seeks to investigate the effects of administering nitrite to pancreatic islet cells that have been removed from a patient for autotransplantation.
What is the current status of trial NCT03544242?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2017-05-07. Estimated completion is 2019-06-27.
What interventions are being tested in trial NCT03544242?
The interventions under investigation include: Control (OTHER), Pre-Isolation Infusion (DRUG), Post-Isolation Infusion (DRUG).
Who is sponsoring clinical trial NCT03544242?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03544242's enrollment target sits among peer trials
4 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI